2 reports on Friday gave AGX the thumbs up - SCE explained why they have moved their valuation from 72c to $1 and bioshares mentioned it again in its list of recommended stocks with superior investment criteria (they recommend selling VCR in the same report). There is also a great piece on how far the biotech run can go - they have a great chart that shows the ASX biotech component has barely started to retract the past 3 years.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.949M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 45361991 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 6100521 | 8 |
View Market Depth
| Last trade - 09.59am 13/08/2025 (20 minute delay) ? |
| CT1 (ASX) Chart |
Day chart unavailable